Key result
Immunoglobulin therapy showed potential beneficial effects against active myocardial damage, recovering left ventricular ejection fraction in patients with myocarditis and cardiomyopathy.
Why the study?
Does immunoglobulin therapy improve outcomes in patients with myocardial diseases and atherosclerosis?
Population
Experimental models and clinical patients with fulminant myocarditis and acute dilated cardiomyopathy
Design
Review
Authors
Loading...
May support randomized trials in myocarditis; leaves open role in atherosclerosis.
Does immunoglobulin therapy improve outcomes in patients with myocardial diseases and atherosclerosis?
Immunoglobulin therapy appears to be a novel and effective treatment strategy for patients with heart failure (myocarditis/cardiomyopathy) and atherosclerosis based on experimental and early clinical studies.
Chiharu Kishimoto (2007) conducted a review in Myocardial diseases and atherosclerosis. Immunoglobulin therapy was evaluated. Immunoglobulin therapy showed potential beneficial effects against active myocardial damage, recovering left ventricular ejection fraction in patients with myocarditis and cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: